Supply Chain Roadmap
Strategic program development for the outbound supply chain.
There is a need to improve the transparency, resilience, and agility of outbound supply chains
The outbound supply chain was built on a blockbuster model and doesn’t fit the needs of the changing pipeline and new modalities. The challenges of the past few years have shown that the outbound supply chain needs to evolve to become more agile, and patient’s expectations have increased as they see what is possible in other supply chains. There is a lack of robust cost-effective options, e.g., direct-to-patient, and vendors are slow to adapt to biopharmaceutical industry changes. This is not surprising when unharmonized regulatory requirements hinder change.
The creation of a transparent patient-centric, resilient, and agile end-to-end supply chain, that consistently delivers high-quality medicines with a focus on delivering an uninterrupted supply chain to our patients
Our members envision a supply chain that can quickly and easily adapt when needed, within a set of implemented industry standard options that will enable cost-effective approaches. With a future-proofed workforce, staff will be better able to manage challenges and oversee a robust and controlled supply chain. Working in collaboration through the associated roadmap, the team wants to shape regulatory guidance for efficient and widespread adoption. Working with partner organizations that have clarity on requirements will enable product development.
Supply Chain Roadmap deliverables
More related workstreams
Our workstreams focus on the areas with the greatest impact across the industry. Led by science, our members are problem-solving today’s sustainability issues. By working with the regulatory governance community, they are also creating future-ready outcomes for the industry.
To find out more about how BioPhorum can help your business, enter your details below and a member of our team will be in touch.